Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study.

Naveen R Elena Nikiphorou Masataka Kuwana Parikshit SenJulius LindblomVishwesh Agarwal James B Lilleker Ai Lyn Tan Babur Salim Nelly Ziadé Tsvetelina V Velikova Abraham Edgar Gracia-Ramos Masataka Kuwana Jessica A Day Ashima Makol Oliver Distler Gabriela Arredondo Hector Chinoy Lisa S Traboco R M Suryo Anggoro Kusumo Wibowo Erick Adrian Zamora Tehozol Jorge Rojas Serrano Ignacio García-De La Torrenull nullRohit Aggarwal Latika Gupta Vikas Agarwal Ioannis Parodis

Published in: Rheumatology (Oxford, England) (2022)

While COVID-19 vaccination-related AEs were reported by four-fifths of SLE patients, those were mostly minor and comparable to AEs reported by healthy individuals, providing reassurance regarding COVID-19 vaccination safety in SLE.

Keyphrases

coronavirus disease
systemic lupus erythematosus
sars cov
end stage renal disease
ejection fraction
newly diagnosed
respiratory syndrome coronavirus
chronic kidney disease
disease activity
peritoneal dialysis
rheumatoid arthritis